Synthesis and Evaluation of 5-(3-(Pyrazin-2-yl)benzylidene)thiazolidine-2,4-dione Derivatives as Pan-Pim Kinases Inhibitors

被引:15
作者
Lee, Jinho [1 ]
Park, Jongseong [1 ]
Hong, Victor Sukbong [1 ]
机构
[1] Keimyung Univ, Dept Chem, Taegu 704701, South Korea
关键词
Pim-1; Pim-2; Pim-3; 5-benzylidenethiazolidine-2,4-dione; pan-pim kinase inhibitor; C-MYC; SERINE/THREONINE KINASES; TRANSGENIC MICE; PROTEIN-KINASES; N-MYC; DISCOVERY; POTENT; TUMORS;
D O I
10.1248/cpb.c14-00325
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pim kinases play a key role in the regulation of signaling pathways including proliferation, migration, and metabolism and are a potential target for cancer therapy. A series of 5-benzylidenethiazolidine-2,4-diones were synthesized as pim kinase inhibitors. The structure-activity relationships (SAR) of the analogues in inhibiting in vitro pim kinase activity as well as the proliferation of leukemia cell lines were examined. SAR studies indicated that a hydroxyl group at the 2-position of the benzene ring of 5-benzylidenethiazolidine-2,4-dione plays an important role in the inhibitory activity against all three pim kinases and replacement with a pyrazinyl group at the 5-position of the benzene ring of 5-benzylidenethiazolidine-2,4-dione improved activity significantly. The compounds exerted anti-proliferative activity against the three leukemia cell lines we tested. The most potent compound, 5i, had an EC50 value of 0.8 mu m in the MV4-11 cell line. The result of kinase profiling indicated that compound Si was highly selective for pim-kinases.
引用
收藏
页码:906 / 914
页数:9
相关论文
共 50 条
[31]   Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2 [J].
Wang, Zhen ;
Zhang, Yali ;
Pinkas, Daniel M. ;
Fox, Alice E. ;
Luo, Jinfeng ;
Huang, Huocong ;
Cui, Shengyang ;
Xiang, Qiuping ;
Xu, Tingting ;
Xun, Qiuju ;
Zhu, Dongsheng ;
Tu, Zhengchao ;
Ren, Xiaomei ;
Brekken, Rolf A. ;
Bullock, Alex N. ;
Liang, Guang ;
Ding, Ke ;
Lu, Xiaoyun .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (17) :7977-7990
[32]   An efficient, catalyst-free and aqueous ethanol-mediated synthesis of 5-((2-aminothiazol-5-yl)(phenyl)methyl)-6-hydroxypyrimidine-2,4(1H,3H)-dione derivatives and their antioxidant activity [J].
Patel, Paras J. ;
Patel, Subham G. ;
Upadhyay, Dipti B. ;
Ravi, Logeswari ;
Dhanasekaran, Anuradha ;
Patel, Hitendra M. .
RSC ADVANCES, 2023, 13 (35) :24466-24473
[33]   Synthesis and biological evaluation of novel 3-(5-substituted-1H-indol-3-yl) pyrrolidine-2,5-dione derivatives with a dual affinity for serotonin 5-HT1A receptor and SERT [J].
Wrobel, Martyna Z. ;
Chodkowski, Andrzej ;
Dawidowski, Maciej ;
Siwek, Agata ;
Stachowicz, Katarzyna ;
Szewczyk, Bernadeta ;
Nowak, Gabriel ;
Satala, Grzegorz ;
Bojarski, Andrzej J. ;
Turlo, Jadwiga .
BIOORGANIC CHEMISTRY, 2023, 141
[34]   Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants [J].
Malik, Sachin ;
Ahuja, Priya ;
Sahu, Kapendra ;
Khan, Suroor Ahmad .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 84 :42-50
[35]   Design, synthesis, and biological evaluation of 1-(5-(benzylthio)-1,3,4-thiadiazol-2-yl)-3-phenylurea derivatives as anticancer agents [J].
Aghcheli, Ayoub ;
Toolabi, Mahsa ;
Ayati, Adileh ;
Moghimi, Setareh ;
Firoozpour, Loghman ;
Bakhshaiesh, Tayebeh Oghabi ;
Nazeri, Elahe ;
Norouzbahari, Maryam ;
Esmaeili, Rezvan ;
Foroumadi, Alireza .
MEDICINAL CHEMISTRY RESEARCH, 2020, 29 (11) :2000-2010
[36]   Synthesis and pharmacological evaluation of novel N-Mannich bases derived from 5,5-diphenyl and 5,5-di(propan-2-yl)imidazolidine-2,4-dione core [J].
Czopek, Anna ;
Byrtus, Hanna ;
Zagorska, Agnieszka ;
Rychtyk, Joanna ;
Gora, Malgorzata ;
Salat, Kinga ;
Rapacz, Anna ;
Obniska, Jolanta .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) :2387-2392
[37]   Design, synthesis, and biological evaluation of 2,4-dimorpholinopyrimidine-5-carbonitrile derivatives as orally bioavailable PI3K inhibitors [J].
Huang, Daowei ;
Yang, Jixia ;
Zhang, Qingwei ;
Zhou, Xiaolei ;
Wang, Yanbo ;
Shang, Zhenhua ;
Li, Jianqi ;
Zhang, Baoyin .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[38]   Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors [J].
Zheng, You-Guang ;
Wang, Jin-An ;
Meng, Long ;
Pei, Xin ;
Zhang, Ling ;
An, Lin ;
Li, Cheng-Lin ;
Miao, Ying-Long .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
[39]   Dual Targeting of VEGFR2 and C-Met Kinases via the Design and Synthesis of Substituted 3-(Triazolo-thiadiazin-3-yl)indolin-2-one Derivatives as Angiogenesis Inhibitors [J].
Mohamady, Samy ;
Galal, Mahmoud ;
Eldehna, Wagdy M. ;
Gutierrez, David C. ;
Ibrahim, Hany S. ;
Elmazar, Mohey M. ;
Ali, Hamed I. .
ACS OMEGA, 2020, 5 (30) :18872-18886
[40]   Design, synthesis and antiepileptic properties of novel 1-(substituted benzylidene)-3-(1-(morpholino/piperidino methyl)-2,3-dioxoindolin-5-yl) urea derivatives [J].
Prakash, Chinnasamy Rajaram ;
Raja, Sundararajan .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (12) :6057-6065